Relief Therapeutics Correlations
| RLF Stock | CHF 5.00 0.06 1.21% |
The current 90-days correlation between Relief Therapeutics and Santhera Pharmaceuticals Holding is 0.07 (i.e., Significant diversification). The correlation of Relief Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Relief Therapeutics Correlation With Market
Good diversification
The correlation between Relief Therapeutics Holding and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and DJI in the same portfolio, assuming nothing else is changed.
Relief |
The ability to find closely correlated positions to Relief Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Relief Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Relief Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Relief Therapeutics Holding to buy it.
Moving together with Relief Stock
| 0.65 | GALE | Galenica Sante AG | PairCorr |
| 0.61 | ZUGN | Zug Estates Holding | PairCorr |
| 0.7 | WARN | Warteck Invest | PairCorr |
| 0.81 | GRKP | Graubuendner Kantonalbank | PairCorr |
Moving against Relief Stock
| 0.81 | IDIA | Idorsia | PairCorr |
| 0.76 | LISP | Chocoladefabriken Lindt | PairCorr |
| 0.73 | LISN | Chocoladefabriken Lindt | PairCorr |
| 0.68 | ZUGER | Zuger Kantonalbank | PairCorr |
| 0.62 | BSLN | Basilea Pharmaceutica | PairCorr |
| 0.56 | XLS | Xlife Sciences AG | PairCorr |
| 0.54 | HBLN | Hypothekarbank Lenzburg | PairCorr |
| 0.52 | BLKB | Basellandschaftliche | PairCorr |
| 0.38 | SNBN | Schweizerische Nationalbank | PairCorr |
Related Correlations Analysis
| 0.16 | 0.83 | 0.77 | 0.71 | VACN | ||
| 0.16 | 0.32 | 0.09 | 0.39 | LONN | ||
| 0.83 | 0.32 | 0.79 | 0.82 | BSLN | ||
| 0.77 | 0.09 | 0.79 | 0.63 | STMN | ||
| 0.71 | 0.39 | 0.82 | 0.63 | SANN | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Relief Stock performing well and Relief Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Relief Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VACN | 1.53 | (0.33) | 0.00 | (3.11) | 0.00 | 2.36 | 13.29 | |||
| LONN | 1.08 | (0.10) | 0.00 | (0.46) | 0.00 | 2.78 | 11.38 | |||
| BSLN | 1.03 | (0.17) | 0.00 | (0.96) | 0.00 | 1.94 | 6.83 | |||
| STMN | 1.50 | (0.11) | 0.00 | 1.12 | 0.00 | 3.28 | 12.01 | |||
| SANN | 1.58 | (0.19) | 0.00 | (0.24) | 0.00 | 3.62 | 14.90 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Relief Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Relief Therapeutics Corporate Management
Elected by the shareholders, the Relief Therapeutics' board of directors comprises two types of representatives: Relief Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Relief. The board's role is to monitor Relief Therapeutics' management team and ensure that shareholders' interests are well served. Relief Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Relief Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeremy CPA | CFO Officer | Profile | |
| David McCullough | Sr Access | Profile | |
| DPhil MBA | Chief Officer | Profile | |
| Jeremy Meinen | Chief Admin | Profile | |
| Dorian Bevec | Chief Lifescience | Profile | |
| Drew CroninFine | Exec Marketing | Profile | |
| Christopher Wick | Sr Sales | Profile |